Salvia miltiorrhiza in Breast Cancer Treatment: A Review of Its Phytochemistry, Derivatives, Nanoparticles, and Potential Mechanisms
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Salvia miltiorrhiza in Breast Cancer Treatment: A Review of Its Phytochemistry, Derivatives, Nanoparticles, and Potential Mechanisms
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-05-05
DOI
10.3389/fphar.2022.872085
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Salvianolic Acid B Protects Intervertebral Discs from Oxidative Stress-Induced Degeneration via Activation of the JAK2/STAT3 Signaling Pathway
- (2021) Shouqian Dai et al. Oxidative Medicine and Cellular Longevity
- Ginsenoside Rb1, salvianolic acid B and their combination modulate gut microbiota and improve glucolipid metabolism in high-fat diet induced obese mice
- (2021) Ying Bai et al. PeerJ
- Tanshinone I and Tanshinone IIA/B attenuate LPS-induced mastitis via regulating the NF-κB
- (2021) Lili Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Breast cancer
- (2021) Sibylle Loibl et al. LANCET
- Tanshinone IIA regulates microRNA‑125b/foxp3/caspase‑1 signaling and inhibits cell viability of nasopharyngeal carcinoma
- (2021) Youhu Wang et al. Molecular Medicine Reports
- Tanshinone IIA Downregulates Lipogenic Gene Expression and Attenuates Lipid Accumulation through the Modulation of LXRα/SREBP1 Pathway in HepG2 Cells
- (2021) Wan-Yun Gao et al. Biomedicines
- Identification of dihydrotanshinone I as an ERp57 inhibitor with anti-breast cancer properties via the UPR pathway
- (2021) Wei Shi et al. BIOCHEMICAL PHARMACOLOGY
- Rosmarinic acid suppresses inflammation, angiogenesis, and improves paclitaxel induced apoptosis in a breast cancer model via NF3 κB-p53-caspase-3 pathways modulation
- (2021) Marwa A. Mahmoud et al. Journal of Applied Biomedicine
- Efficacy and safety of Salvia miltiorrhiza (Salvia miltiorrhiza Bunge) and ligustrazine injection in the adjuvant treatment of early-stage diabetic kidney disease: A systematic review and meta-analysis
- (2021) Fan Xie et al. JOURNAL OF ETHNOPHARMACOLOGY
- Tanshinone I regulates autophagic signaling via the activation of AMP-activated protein kinase in cancer cells
- (2020) Lihua Zheng et al. ANTI-CANCER DRUGS
- Protective effect of tanshinone IIA on H2O2-induced oxidative stress injury in rat cardiomyocytes by activating Nrf2 pathway
- (2020) Guang Yang et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Neuroprotective Effect of Salvianolic Acid A against Diabetic Peripheral Neuropathy through Modulation of Nrf2
- (2020) Chunyang Xu et al. Oxidative Medicine and Cellular Longevity
- Tanshinone II A enhances pyroptosis and represses cell proliferation of HeLa cells by regulating miR-145/GSDMD signaling pathway
- (2020) Wenjuan Tong et al. BIOSCIENCE REPORTS
- Targeting apoptosis in cancer therapy
- (2020) Benedito A. Carneiro et al. Nature Reviews Clinical Oncology
- The Attenuation of Traumatic Brain Injury via Inhibition of Oxidative Stress and Apoptosis by Tanshinone IIA
- (2020) Yongpan Huang et al. Oxidative Medicine and Cellular Longevity
- Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis
- (2020) Ying Liu et al. JOURNAL OF NANOBIOTECHNOLOGY
- Inhibition of PI3K/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells
- (2020) Danning Shi et al. BMC Pharmacology & Toxicology
- FGFR2/STAT3 Signaling Pathway Involves in the Development of MMTV-Related Spontaneous Breast Cancer in TA2 Mice
- (2020) Jiaxing Du et al. Frontiers in Oncology
- Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells
- (2020) Samia S. Messeha et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Salvianolic Acid B Improves Postresuscitation Myocardial and Cerebral Outcomes in a Murine Model of Cardiac Arrest: Involvement of Nrf2 Signaling Pathway
- (2020) Qing-Qi Ji et al. Oxidative Medicine and Cellular Longevity
- Cryptotanshinone: A review of its pharmacology activities and molecular mechanisms
- (2020) Yan-Hong Wu et al. FITOTERAPIA
- Tanshinone II A improves the chemosensitivity of breast cancer cells to doxorubicin by inhibiting β‐catenin nuclear translocation
- (2020) Shizheng Li et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Véronique Diéras et al. LANCET ONCOLOGY
- Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)
- (2020) Hang Zhang et al. MEDICINAL RESEARCH REVIEWS
- The Effect of Salvianolic Acid on Vascular Protection and Possible Mechanisms
- (2020) Yalan Wu et al. Oxidative Medicine and Cellular Longevity
- An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus
- (2020) Bei‐di Chen et al. Arthritis & Rheumatology
- Astragalus membranaceus and Salvia miltiorrhiza ameliorates cyclosporin A-induced chronic nephrotoxicity through the “gut-kidney axis”
- (2020) Cong Han et al. JOURNAL OF ETHNOPHARMACOLOGY
- Cancer Stem Cells: The Architects of the Tumor Ecosystem
- (2019) Briana C. Prager et al. Cell Stem Cell
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells
- (2019) Vincenzo Ingangi et al. Frontiers in Oncology
- Inhibition of FOXO3a/BIM signaling pathway contributes to the protective effect of salvianolic acid A against cerebral ischemia/reperfusion injury
- (2019) Junke Song et al. Acta Pharmaceutica Sinica B
- Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway
- (2019) Su-Lim Kim et al. Oxidative Medicine and Cellular Longevity
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs/mTOR-dependent autophagy pathway
- (2019) Xuefeng Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer
- (2019) Johanna Wagner et al. CELL
- Sodium tanshinone IIA sulfonate prevents the adverse left ventricular remodelling: Focus on polymorphonuclear neutrophil‐derived granule components
- (2019) Shuai Mao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
- (2019) Wen Shen et al. NATURE BIOTECHNOLOGY
- Salvianolic Acid C against Acetaminophen-Induced Acute Liver Injury by Attenuating Inflammation, Oxidative Stress, and Apoptosis through Inhibition of the Keap1/Nrf2/HO-1 Signaling
- (2019) Chien-Ta Wu et al. Oxidative Medicine and Cellular Longevity
- Salvia miltiorrhiza in diabetes: A review of its pharmacology, phytochemistry, and safety
- (2019) Qiangqiang Jia et al. PHYTOMEDICINE
- Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer
- (2019) Kun Li et al. PHYTOTHERAPY RESEARCH
- TanshinoneⅡA phenanthroimidazole derivative polarizes macrophage to improve metabolic homeostasis
- (2019) Lei Ma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal 18F-FES PET/CT
- (2019) SiMin He et al. Contrast Media & Molecular Imaging
- Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin-like growth factor-1 receptor/phosphatidylinositol-3-kinase signaling pathway
- (2019) Yu-ting Wu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Tanshinone IIA protects hypoxia-induced injury by preventing microRNA-28 up-regulation in PC-12 cells
- (2019) Nan Tang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Current Progress of Research on Neurodegenerative Diseases of Salvianolic Acid B
- (2019) Rui Zhao et al. Oxidative Medicine and Cellular Longevity
- Pharmacological activities of dihydrotanshinone I, a natural product from Salvia miltiorrhiza Bunge
- (2019) Xiuping Chen et al. PHARMACOLOGICAL RESEARCH
- Effects and Mechanism of Tanshinone II A in Proliferation, Apoptosis, and Migration of Human Colon Cancer Cells
- (2019) Junlai Xue et al. MEDICAL SCIENCE MONITOR
- E-cadherin is required for metastasis in multiple models of breast cancer
- (2019) Veena Padmanaban et al. NATURE
- Role of ATP-binding cassette transporters in cancer initiation and progression
- (2019) Stefania Nobili et al. SEMINARS IN CANCER BIOLOGY
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Recovery of chicken growth plate by TanshinoneⅡA through wnt/β-catenin pathway in thiram-induced Tibial Dyschondroplasia
- (2019) Hao Yang et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- Salvianolic Acid B Slows the Progression of Breast Cancer Cell Growth via Enhancement of Apoptosis and Reduction of Oxidative Stress, Inflammation, and Angiogenesis
- (2019) Mohamed A. Katary et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tanshinone I Inhibits IL-1β-Induced Apoptosis, Inflammation And Extracellular Matrix Degradation In Chondrocytes CHON-001 Cells And Attenuates Murine Osteoarthritis
- (2019) Xipeng Wang et al. Drug Design Development and Therapy
- Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice
- (2019) Shan Gao et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis
- (2019) Jennifer J Gao et al. LANCET ONCOLOGY
- Tanshinone IIA contributes to the pathogenesis of endometriosis via renin angiotensin system by regulating the dorsal root ganglion axon sprouting
- (2019) Zhen-zhen Chen et al. LIFE SCIENCES
- Salvianolic acid A attenuates kidney injury and inflammation by inhibiting NF-κB and p38 MAPK signaling pathways in 5/6 nephrectomized rats
- (2018) Hong-feng Zhang et al. ACTA PHARMACOLOGICA SINICA
- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†
- (2018) F Cardoso et al. ANNALS OF ONCOLOGY
- Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer
- (2018) Jasmine Miller-Kleinhenz et al. BIOMATERIALS
- Cardio-protection of ultrafine granular powder for Salvia miltiorrhiza Bunge against myocardial infarction
- (2018) Linlin Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Tanshinone IIA effects on ovarian cancer cell line
- (2018) Nan Li et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer’s disease
- (2018) Francesco Maione et al. PHARMACOLOGICAL RESEARCH
- Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA
- (2018) Zhenyu Xu et al. PHYTOMEDICINE
- Cytotoxicity of Tanshinone IIA combined with Taxol on drug-resist breast cancer cells MCF-7 through inhibition of Tau
- (2018) Hui Lin et al. PHYTOTHERAPY RESEARCH
- Chemical characterization and bioactive properties of decoctions and hydroethanolic extracts of Thymus carnosus Boiss.
- (2018) Carlos Martins-Gomes et al. Journal of Functional Foods
- The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG
- (2018) Chao Lv et al. Cell Death & Disease
- Tanshinone sensitized the antitumor effects of irradiation on laryngeal cancer via JNK pathway
- (2018) Hui Xu et al. Cancer Medicine
- Expression profiling of genes modulated by rosmarinic acid (RA) in MCF-7 breast cancer cells
- (2018) Bogna Juskowiak et al. Ginekologia Polska
- Chemoprotective Efficacy of Salvianolic Acid B via Triggering Apoptosis in MCF-7 Human Breast Cancer Cells
- (2018) Yaozhen Pan et al. International Journal of Pharmacology
- Tanshinone I attenuates proliferation and chemoresistance of cervical cancer in a KRAS-dependent manner
- (2018) Sidi Dun et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Tanshinone-IIA-Based Analogues of Imidazole Alkaloid Act as Potent Inhibitors To Block Breast Cancer Invasion and Metastasis in Vivo
- (2018) Qiong Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
- (2018) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy
- (2018) Wenda Zhang et al. Cell Death & Disease
- Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells via ceramide-mediated apoptosis
- (2018) Wei Sha et al. Oncotarget
- Anti-allergic effects of salvianolic acid A and tanshinone IIA from Salvia miltiorrhiza determined using in vivo and in vitro experiments
- (2018) Jae-Yeong Heo et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Cryptotanshinone inhibition of mammalian target of rapamycin pathway is dependent on oestrogen receptor alpha in breast cancer
- (2017) Yanhong Pan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)
- (2017) Joanne L. Blum et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
- (2017) Carsten Denkert et al. LANCET
- Salvianolic Acid Exerts Cardioprotection through Promoting Angiogenesis in Animal Models of Acute Myocardial Infarction: Preclinical Evidence
- (2017) Long-jie Yu et al. Oxidative Medicine and Cellular Longevity
- Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K/Akt and mitochondrial-associated apoptotic pathway
- (2017) Bing Han et al. PHYTOMEDICINE
- Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage
- (2017) Biying Ji et al. Translational Stroke Research
- Sodium tanshinone IIA sulfate adjunct therapy reduces high-sensitivity C-reactive protein level in coronary artery disease patients: a randomized controlled trial
- (2017) Siming Li et al. Scientific Reports
- Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model
- (2016) Yu-cai Chen et al. ACTA PHARMACOLOGICA SINICA
- Tanshinone I induces apoptosis and pro-survival autophagy in gastric cancers
- (2016) Xiaoping Jing et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways
- (2016) Mingjie Lu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis
- (2016) Johanna Holm et al. JOURNAL OF CLINICAL ONCOLOGY
- Treating cancer with selective CDK4/6 inhibitors
- (2016) Ben O'Leary et al. Nature Reviews Clinical Oncology
- Roles of Reactive Oxygen Species in Anticancer Therapy withSalvia miltiorrhiza Bunge
- (2016) Yu-Chiang Hung et al. Oxidative Medicine and Cellular Longevity
- Protein arginine methyltransferase 1 may be involved in pregnane x receptor-activated overexpression of multidrug resistance 1 gene during acquired multidrug resistant
- (2016) Tingting Li et al. Oncotarget
- Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer
- (2016) Ahmad Awada et al. JAMA Oncology
- Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2
- (2015) Xiaowei Zheng et al. CANCER BIOLOGY & THERAPY
- The role for autophagy in cancer
- (2015) Eileen White JOURNAL OF CLINICAL INVESTIGATION
- The combination of arsenic and cryptotanshinone induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in breast cancer cells
- (2015) Yan Fang Zhang et al. Metallomics
- Anabolic Effect of the Traditional Chinese Medicine Compound Tanshinone IIA on Myotube Hypertrophy Is Mediated by Estrogen Receptor
- (2015) Piwen Zhao et al. PLANTA MEDICA
- The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways
- (2015) Mounia Guerram et al. Oncotarget
- Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function
- (2015) Vito Giuseppe D’Agostino et al. Scientific Reports
- Tanshinone IIA Inhibits HIF-1α and VEGF Expression in Breast Cancer Cells via mTOR/p70S6K/RPS6/4E-BP1 Signaling Pathway
- (2015) Guobing Li et al. PLoS One
- Cryptotanshinone Induces Inhibition of Breast Tumor Growth by Cytotoxic CD4+ T Cells through the JAK2/STAT4/ Perforin Pathway
- (2014) Jun Zhou et al. Asian Pacific Journal of Cancer Prevention
- Cryptotanshinone inhibits breast cancer cell growth by suppressing estrogen receptor signaling
- (2014) Shanhu Li et al. CANCER BIOLOGY & THERAPY
- Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy
- (2014) Cong Luo et al. JOURNAL OF CONTROLLED RELEASE
- Salvia miltiorrhiza: An ancient Chinese herbal medicine as a source for anti-osteoporotic drugs
- (2014) Yubo Guo et al. JOURNAL OF ETHNOPHARMACOLOGY
- Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines
- (2014) LI WANG et al. Molecular Medicine Reports
- Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines
- (2014) PEIFEN FU et al. ONCOLOGY REPORTS
- Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway
- (2014) Jiangxia Cai et al. PHYTOMEDICINE
- Synergistic and Antagonistic Drug Combinations Depend on Network Topology
- (2014) Ning Yin et al. PLoS One
- Tanshinone I Activates the Nrf2-Dependent Antioxidant Response and Protects Against As(III)-Induced Lung Inflammation In Vitro and In Vivo
- (2013) Shasha Tao et al. ANTIOXIDANTS & REDOX SIGNALING
- Complex diseases require complex therapies
- (2013) Ravi Iyengar EMBO REPORTS
- Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways
- (2013) Caiyu Lin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tanshinone IIA Induces Autophagic Cell Death via Activation of AMPK and ERK and Inhibition of mTOR and p70 S6K in KBM-5 Leukemia Cells
- (2013) Sun-Mi Yun et al. PHYTOTHERAPY RESEARCH
- Pharmaceutical nanotechnology for oral delivery of anticancer drugs
- (2012) Lin Mei et al. ADVANCED DRUG DELIVERY REVIEWS
- Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression
- (2012) Chin-Cheng Su INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Tanshinone IIA inhibits human breast cancer MDA-MB-231 cells by decreasing LC3-II, Erb-B2 and NF-κBp65
- (2012) CHIN-CHENG SU et al. Molecular Medicine Reports
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- Tanshinones Inhibit the Growth of Breast Cancer Cells through Epigenetic Modification of Aurora A Expression and Function
- (2012) Yi Gong et al. PLoS One
- Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis
- (2012) Xiao-Wen Jiang et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Cryptotanshinone induces ER stress-mediated apoptosis in HepG2 and MCF7 cells
- (2011) In-Ja Park et al. APOPTOSIS
- Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics
- (2011) Jean-Claude Martinou et al. DEVELOPMENTAL CELL
- Tanshinone IIA Induces Mitochondria Dependent Apoptosis in Prostate Cancer Cells in Association with an Inhibition of Phosphoinositide 3-Kinase/AKT Pathway
- (2010) Suk-Hyun Won et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway
- (2010) Hong-Lei Tian et al. CANCER LETTERS
- Inhibition of Bone Metastasis from Breast Carcinoma by Rosmarinic Acid
- (2010) Yichun Xu et al. PLANTA MEDICA
- Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer
- (2009) Lu INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules
- (2008) I. T. Nizamutdinova et al. CARCINOGENESIS
- Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion
- (2007) Jing-Yan Han et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More